GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Equity-to-Asset

SanBio Co (TSE:4592) Equity-to-Asset : 0.55 (As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SanBio Co's Total Stockholders Equity for the quarter that ended in Jan. 2024 was 円2,792.40 Mil. SanBio Co's Total Assets for the quarter that ended in Jan. 2024 was 円5,047.29 Mil.

The historical rank and industry rank for SanBio Co's Equity-to-Asset or its related term are showing as below:

TSE:4592' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05   Med: 0.63   Max: 0.77
Current: 0.55

During the past 11 years, the highest Equity to Asset Ratio of SanBio Co was 0.77. The lowest was -0.05. And the median was 0.63.

TSE:4592's Equity-to-Asset is ranked worse than
60.5% of 1562 companies
in the Biotechnology industry
Industry Median: 0.67 vs TSE:4592: 0.55

SanBio Co Equity-to-Asset Historical Data

The historical data trend for SanBio Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Equity-to-Asset Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.63 0.37 0.63 0.55

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.65 0.46 0.44 0.55

Competitive Comparison of SanBio Co's Equity-to-Asset

For the Biotechnology subindustry, SanBio Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SanBio Co's Equity-to-Asset falls into.



SanBio Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SanBio Co's Equity to Asset Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Equity to Asset (A: Jan. 2024 )=Total Stockholders Equity/Total Assets
=2792.398/5047.291
=

SanBio Co's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )=Total Stockholders Equity/Total Assets
=2792.398/5047.291
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (TSE:4592) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SanBio Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SanBio Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines